256 related articles for article (PubMed ID: 9058727)
1. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
2. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
4. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
[TBL] [Abstract][Full Text] [Related]
6. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line.
Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Improta S; Juzbasic S; Todesco M; Perin V; Gattei V; Herrmann F; Gruss HJ; Carbone A
Blood; 1996 Nov; 88(9):3299-305. PubMed ID: 8896393
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.
Maio M; Pinto A; Carbone A; Zagonel V; Gloghini A; Marotta G; Cirillo D; Colombatti A; Ferrara F; Del Vecchio L
Blood; 1990 Aug; 76(4):783-90. PubMed ID: 1974471
[TBL] [Abstract][Full Text] [Related]
8. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
Hsu PL; Hsu SM
Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
[TBL] [Abstract][Full Text] [Related]
9. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
10. CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
[TBL] [Abstract][Full Text] [Related]
11. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
12. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.
Mori M; Manuelli C; Pimpinelli N; Mavilia C; Maggi E; Santucci M; Bianchi B; Cappugi P; Giannotti B; Kadin ME
Blood; 1999 Nov; 94(9):3077-83. PubMed ID: 10556192
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms.
Horie R; Gattei V; Ito K; Imajo-Ohmi S; Tange T; Miyauchi J; Pinto A; Degan M; De Iuliis A; Tassan Mazzocco F; Rossi FM; Higashihara M; Watanabe T
Am J Pathol; 1999 Dec; 155(6):2029-41. PubMed ID: 10595933
[TBL] [Abstract][Full Text] [Related]
14. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.
Gruss HJ; Boiani N; Williams DE; Armitage RJ; Smith CA; Goodwin RG
Blood; 1994 Apr; 83(8):2045-56. PubMed ID: 8161776
[TBL] [Abstract][Full Text] [Related]
16. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
Wendtner CM; Schmitt B; Gruss HJ; Druker BJ; Emmerich B; Goodwin RG; Hallek M
Cancer Res; 1995 Sep; 55(18):4157-61. PubMed ID: 7545087
[TBL] [Abstract][Full Text] [Related]
17. Construction and expression of a soluble form of human CD30 ligand with functional activity.
Powell IF; Li T; Jäck HM; Ellis TM
J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
[TBL] [Abstract][Full Text] [Related]
18. Study of gene expression of CD30 variant (CD30v) and CD30 ligand (CD30L) in acute leukemia.
Essa EA; El Halim SM; Abo-Elenin A; El Bendary A; Abdou SH; Farag W
Egypt J Immunol; 2007; 14(1):11-20. PubMed ID: 18689277
[TBL] [Abstract][Full Text] [Related]
19. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
[TBL] [Abstract][Full Text] [Related]
20. The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells.
Gruss HJ; Scheffrahn I; Hubinger G; Duyster J; Hermann F
Leukemia; 1996 May; 10(5):829-35. PubMed ID: 8656679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
